Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Angiotensin II by Platform Therapeutics for Muscle Spasm: Likelihood of Approval
Angiotensin II is under clinical development by Platform Therapeutics and currently in Phase I for Muscle Spasm. According to GlobalData,...